Bendamustine plus Rituximab (BR) Chemoimmunotherapy and Maintenance Lenalidomide in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Wisconsin Oncology Network (WON) Study

被引：0

作者：

Chang, Julie E. ^{[1
]}

Zhang, Chong ^{[2
]}

Kim, KyungMann ^{[2
]}

Kirby, Rachel ^{[3
]}

Volk, Lynn ^{[3
]}

Werndli, Jae ^{[1
]}

Go, Ronald S. ^{[4
]}

Weiss, Matthias ^{[5
]}

Blank, Jules H. ^{[6
]}

Thompson, Michael A. ^{[7
]}

Farnen, John P.

Cole, Craig E.

Bseiso, Ali W. ^{[5
]}

Volk, Michael ^{[6
]}

Bayer, Gerald ^{[6
]}

Wassenaar, Tim ^{[7
]}

Mansky, Patrick ^{[8
]}

Traynor, Anne ^{[1
]}

Fenske, Timothy S. ^{[9
]}

Kahl, Brad S. ^{[1
]}

机构：

[1] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI USA

[2] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Madison, WI USA

[3] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[4] Gundersen Lutheran Hlth Syst, Ctr Canc & Blood Disorders, La Crosse, WI USA

[5] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA

[6] St Vincent Reg Canc Ctr, Green Bay, WI USA

[7] ProHlth Care Reg Canc Ctr, Waukesha, WI USA

[8] Bellin Mem Hosp, Green Bay, WI USA

[9] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.3647.3647

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

3647

引用

页数：2

共 50 条

[1] Bendamustine plus rituximab chemoimmunotherapy and maintenance lenalidomide in relapsed, refractory chronic lymphocytic leukaemia and small lymphocytic lymphoma: AWisconsin Oncology Network Study
Chang, Julie E.
Havighurst, Thomas
Kim, KyungMann
Eickhoff, Jens
Traynor, Anne M.
Kirby-Slimp, Rachel
Volk, Lynn M.
Werndli, Jae
Go, Ronald S.
Weiss, Matthias
Blank, Jules
Kahl, Brad S.
BRITISH JOURNAL OF HAEMATOLOGY, 2016, 173 (02) : 283 - 291
[2] ACALABRUTINIB VS IDELALISIB PLUS RITUXIMAB (IDR) OR BENDAMUSTINE PLUS RITUXIMAB (BR) IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): FINAL RESULTS OF ASCEND
Ghia, Paolo
Pluta, Andrzej
Wach, Malgorzata
Lysak, Daniel
Kozak, Tomas
Simkovic, Martin
Kaplan, Polina
Kraychok, Iryna
Illes, Arpad
De la Serna, Javier
Dolan, Sean
Campbell, Philip
Musuraca, Gerardo
Jacob, Abraham
Avery, Eric J.
Lee, Jae Hoon
Wang, Denise
Patel, Priti
Jurcza, Wojciech
HAEMATOLOGICA, 2020, 105 : 205 - 206
[3] Acalabrutinib Versus Idelalisib Plus Rituximab (IdR) or Bendamustine Plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
Ghia, Paolo
Pluta, Andrzej
Wach, Malgorzata
Lysak, Daniel
Kozak, Tomas
Simkovic, Martin
Kaplan, Polina
Kraychok, Iryna
Illes, Arpad
de la Serna, Javier
Dolan, Sean
Campbell, Philip
Musuraca, Gerardo
Jacob, Abraham
Avery, Eric J.
Lee, Jae Hoon
Wang, Denise
Patel, Priti
Jurczak, Wojciech
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S220 - S221
[4] Phase 3 BELLWAVE-010: Nemtabrutinib Plus Venetoclax Versus Venetoclax Plus Rituximab (VR) in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Lavie, David
Ozcan, Muhit
Chaudhry, Arvind
Zhou, Xuan
Paydar, Ima
Farooqui, Mohammed Z. H.
Ghia, Paolo
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S353 - S353
[5] Acalabrutinib (Acala) vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND final results
Welslau, M.
Ghia, P.
Pluta, A.
Wach, M.
Lysak, D.
Kozak, T.
Simkovic, M.
Kaplan, P.
Kraychok, I
Illes, A.
de la Serna, J.
Dolan, S.
Campbell, P.
Musuraca, G.
Jacob, A.
Avery, E. J.
Lee, J. H.
Wang, D.
Patel, P.
Quah, C.
Jurczak, W.
ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 71 - 72
[6] Acalabrutinib (Acala) vs Idelalisib plus Rituximab (IdR) or Bendamustine plus Rituximab (BR) in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL): ASCEND Final Results
Jacob, Abraham
Ghia, Paolo
Pluta, Andrzej
Wach, Malgorzata
Lysak, Daniel
Kozak, Tomas
Simkovic, Martin
Kaplan, Polina
Kraychok, Iryna
Illes, Arpad
De La Serna, Javier
Dolan, Sean
Campbell, Philip
Musuraca, Gerardo
Avery, Eric Joseph
Lee, Jae Hoon
Wang, Denise
Patel, Priti
Quah, Cheng Seok
Jurczak, Wojciech
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 : 141 - 142
[7] Acalabrutinib (Acala) versus idelalisib plus rituximab (IdR) or bendamustine plus rituximab (BR) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): ASCEND final results.
Ghia, Paolo
Pluta, Andrzej
Wach, Malgorzata
Lysak, Daniel
Kozak, Tomas
Simkovic, Martin
Kaplan, Polina
Kraychok, Iryna
Illes, Arpad
De La Serna, Javier
Dolan, Sean
Campbell, Philip
Musuraca, Gerardo
Jacob, Abraham
Avery, Eric Joseph
Lee, Jae Hoon
Wang, Denise
Patel, Priti
Quah, Cheng Seok
Jurczak, Wojciech
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[8] Final 5-year updated results from a phase 3 study (HELIOS) of ibrutinib plus bendamustine and rituximab (BR) in patients with relapsed/refractory chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL)
Fraser, Graeme
Chanan-Khan, Asher
Demirkan, Faith
Silva, Rodrigo Santucci
Grosicki, Sebastian
Janssens, Ann
Mayer, Jiri
Bartlett, Nancy
Dilhuydy, Marie Sarah
Loscertales, Javier
Avigdor, Abraham
Rule, Simon
Samoilova, Olga
Pavlosky, Miguel
Hallek, Michael
Salman, Mariya
Tamegnon, Monelle
Sun, Steven
Connor, Anne
Nottage, Kerri
Balasubramanian, Sriram
Howes, Angela
Cramer, Paula
LEUKEMIA & LYMPHOMA, 2020, 61 : 106 - 108
[9] The PI3K Inhibitor ME-401 ± Rituximab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Pagel, John
Zelenetz, Andrew
Reddy, Nishitha
Jagadeesh, Deepa
Stathis, Anastasios
Salman, Huda
Soumerai, Jacob
Kenkre, Vaishalee
Asch, Adam
Jhangiani, Haresh
Llorin-Sangalang, Judith
Wood, Jamie
Gorbatchevsky, Igor
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S32 - S32
[10] Improvement of Quality of Response with Ibrutinib Plus Bendamustine/Rituximab Vs Placebo Plus Bendamustine/Rituximab for Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
Cramer, Paula
Chanan-Khan, Asher
Fraser, Graeme
Demirkan, Fatih
Silva, Rodrigo Santucci
Pylypenko, Halyna
Grosicki, Sebastian
Janssens, Ann
Goy, Andre
Mayer, Jiri
Dilhuydy, Marie Sarah
Loscertales, Javier
Bartlett, Nancy L.
Avigdor, Abraham
Rule, Simon
Sun, Steven
Phelps, Charles
Mahler, Michelle
Salman, Mariya
Schaffer, Michael
Balasubramanian, Sriram
Howes, Angela
Hallek, Michael
BLOOD, 2015, 126 (23)

← 1 2 3 4 5 →